Nicholas Ball - Concepedia

Author

Nicholas Ball

Also Known As

Ball, Nicholas, N Ball, N S Ball, N. Ball, N.S. Ball, Nancy Ball, Natalie Ball, Nathaniel Ball, Navah Ball, Nicholas Ball

Publications

Citations

H-Index

Concepts

All Affiliations

Dow Chemical (United States)BASF (Germany)Huntsman (United States)Sasol (Germany)AkzoNobel (Sweden)

About

Nicholas Ball is an author at Dow Chemical (United States) specializing in engineering, medicine, and bioanalysis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	7	7	309
2	Medicine	5	5	175
3	Social Sciences	2	2	118
4	Business	1	1	13
5	Public Health	1	1	56

Nicholas Ball

Publications

809

Citations

H-Index

Page 1

	Year	Citations
Toward Good Read-Across Practice (GRAP) guidance Nicholas Ball ALTEX	2016	197
Use of category approaches, read-across and (Q)SAR: General considerations Grace Patlewicz, Nicholas Ball, Ewan D. Booth, Regulatory Toxicology and Pharmacology RadarEngineeringMeasurementSynthetic Aperture RadarImaging Radar	2013	130
A framework for chemical safety assessment incorporating new approach methodologies within REACH Nicholas Ball, R. Bars, Philip A. Botham, Archives of Toxicology	2022	85
Evaluating the sensitization potential of surfactants: Integrating data from the local lymph node assay, guinea pig maximization test, and in vitro methods in a weight-of-evidence approach Nicholas Ball, Stuart Z. Cagen, Juan-Carlos Carrillo, Regulatory Toxicology and Pharmacology EngineeringImmunotoxicologySurfactantsDermatologyVitro Methods	2011	77
Building scientific confidence in the development and evaluation of read-across Grace Patlewicz, Nicholas Ball, Peter J. Boogaard, Regulatory Toxicology and Pharmacology Cognitive ScienceReading ComprehensionCognitive DevelopmentReadingCognition	2015	68
The challenge of using read-across within the EU REACH regulatory framework; how much uncertainty is too much? Dipropylene glycol methyl ether acetate, an exemplary case study Nicholas Ball, Michael Bartels, Robert A. Budinsky, Regulatory Toxicology and Pharmacology Exemplary Case StudyRegulatory ApprovalMuch UncertaintyHealth PolicyGlobal Health	2014	56
Application of a weight of evidence approach to assessing discordant sensitisation datasets: Implications for REACH David Basketter, Nicholas Ball, Stuart Z. Cagen, Regulatory Toxicology and Pharmacology Evidence ApproachDataset CreationBiasCognitionSocial Sciences	2009	50
Comparative testing for the identification of skin-sensitizing potentials of nonionic sugar lipid surfactants Christine Garcia, Nicholas Ball, Stuart Z. Cagen, Regulatory Toxicology and Pharmacology Lipid AnalysisEngineeringComparative TestingMedicineBioanalysis	2010	30
Neuron-specific hel-N1 and HuD as novel molecular markers of neuroblastoma: a correlation of HuD messenger RNA levels with favorable prognostic features. Nicholas Ball, Peter H. King PubMed PathologyFavorable Prognostic FeaturesTumor BiologyNeuro-oncologyHud Expression	1997	24
Predicting the future: opportunities and challenges for the chemical industry to apply 21st-century toxicity testing. Raja S. Settivari, Nicholas Ball, Lynea Murphy, PubMed EngineeringIndustrial ChemicalsToxicology TestingStrategic ApplicationWhereas Conventional Toxicology	2015	24

Page 1